Controlled Release

To maintain potency, stability, and shelf life, pharmaceuticals and healthcare products often require highly protective and active packaging. Colorcon now provides critical industries with high-quality, controlled atmosphere packaging, so they can protect their products from moisture and oxygen.

Digital self-serve platform to boost R&D productivity through interactive formulation development.

Colorcon offers a wide range of film coating products, all of which can be formulated specifically for your application and regulatory requirements. Whether the desired function for your tablet or multiparticulate dosage is immediate release, enteric release and/or sustained release, we have the film coati...

In the development of a solid oral dosage form, the choice of the core excipients is extremely important. Key aspects for consideration are the nature of the active pharmaceutical ingredient (API) itself; the intended delivery method of the API (immediate or modified release) and the manufacturing process.

New OneLock Closure Designed for Simple Integration into Existing Production Lines

For over four decades, we’ve led the film coating industry through innovation, unmatched expertise, and solutions designed to perform. Trusted by top pharmaceutical and nutraceutical brands worldwide, our leadership is built on proven results.

In 1980, The Empire Strikes Back, part of the popular Star Wars franchise, dominated the box office. Former actor, Ronald Reagan, took office as the 40th President of the United States. And during that same year, a quieter—but we would argue, equally transformative—moment unfolded in pharmaceutical manufacturing: Opadry®, the first-of-its-kind complete film coating system, entered the market. Opadry was the original fully formulated film coating system for solid oral dosage forms—marking a new era of reliability, consistency and simplicity for pharmaceutical companies worldwide.

OneLock™ is an all‑in‑one integrated closure system designed to simplify packaging while delivering reliable moisture protection, safety features, and regulatory confidence across global markets.

On August 6th, 2025, the European Commission published a Staff Working Document reaffirming its position: Titanium dioxide remains approved for use as a colorant in medicinal products under Regulation (EU) 2022/63. This decision follows the European Medicines Agency’s (EMA) April 2024 review.

Phytolon leverages bio-production and precision fermentation to create natural food colors

The Johor plant is Colorcon’s 7th major film coating plant and their 16th manufacturing facility worldwide.

Harleysville, Pennsylvania, USA, 23 January 2024. 

Colorcon, a world leader in the development and supply of film coating systems, specialty excipients, and functional packaging for the healthcare industries, announces the launch of a new Opadry® titanium dioxide (TiO2)-free film coating system for pharmaceutical tablets.

Harleysville, Pennsylvania, USA, 2nd March 2023, Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, today announces that it has completed the acquisition of Airnov Healthcare Packaging, Inc. from Arsenal Capital Partners.